ClinicalTrials.gg
Drug

Idarucizumab clinical trials

Also written BI 655075.

studies test it
7
open now
0
in phase 3
4
first study started
2012

How each study uses idarucizumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
16 Oct 2015 · PRAXBIND · BLA 761025 (FDA, Drugs@FDA)
European Union
20 Nov 2015 · Praxbind · EMEA/H/C/003986 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Idarucizumab
5
PRAXBIND, Praxbind, Prizbind
2

Development codes

BI 655075
2

Studies by the year they started

7 studies that test it; most in 2016 (2)

Studies that test idarucizumab, by start year
YearStudies
20121
20131
20141
20162
20171
20181

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 3
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 0

Boehringer Ingelheim (7)

Often tested with

Tested in the same studies.

Dabigatran (1)

Studies

Open first, then newest update. How each study uses idarucizumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 7

Given beside what is tested · 1 — idarucizumab is usual care or a partner of the new treatment

Codes

What other systems call idarucizumab · ClinicalTrials.gg INT000155

  • MeSH (NLM) C000594745idarucizumabOne source NLM
  • UNII (FDA) 97RWB5S1U6IDARUCIZUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 1716191Confirmed FDA, Wikidata
  • Wikidata Q17630273IdarucizumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C128646IdarucizumabOne source FDA
  • DrugBank DB09264One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.